| http://www.w3.org/ns/prov#value | - Among these challenges are rapid changes in disease patterns, which will increasingly shift toward ???lifestyle??? diseases more common in the U.S., Europe, and other established markets, Booz & Co. concluded in ???Pharma Emerging Markets 2.0: How Emerging Markets are Driving the Transformation of the Pharmaceutical Industry.???
|
